Yoga for Breast Cancer
Conditions
Women With Stage I or II Breast Cancer Undergoing Active Radiation Therapy
Conditions: official terms
Breast Neoplasms
Study Type
Interventional
Study Phase
N/A
Study Design
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Primary Purpose: Supportive Care
Intervention
Name: Yoga
Type: Other
Overall Status
Recruiting
Summary
The purpose of this study is to examine the use of Eischens yoga for 8 weeks in one cohort of 20 women with stage I and II breast cancer receiving radiation therapy treatment, while a second cohort of the same type of and number of patients who, instead of yoga will receive standard supportive therapy, Questionnaire measuring cancer-related quality of life (FACT-G instrument) and fatigue (Brief Fatique Inventory) will be given to patients at several points.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- Stage I and II breast cancer patients undergoing active radiation therapy

- Above the age of 18

- Must sign informed consent form

- Must speak English

- Only women are eligible

Exclusion Criteria:

- Patients with medical restrictions that may interfere with yoga participation per their physicians' decision

- Those who have smoked in the last 6 months because smoking can interfere with the breathing and relaxation techniques of yoga.

- Those who have regularly taken yoga in the last 6 months, because they would not come to the intervention with the same baseline as other participants.
Location
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Status: Recruiting
Contact: Lilie Lin, MD - 855-216-0098 - PennCancerTrials@emergingmed.com
Start Date
March 2013
Completion Date
March 2014
Sponsors
Abramson Cancer Center of the University of Pennsylvania
Source
Abramson Cancer Center of the University of Pennsylvania
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page